Sentiment-Signal
27,1
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
43.5
0 neu, 1 erhöht, -15066733K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Unternehmen & Branche
| Name | QUEST DIAGNOSTICS INC |
|---|---|
| Ticker | DGX |
| CIK | 0001022079 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | 74834l100 |
|---|---|
| ISIN | US74834L1008 |
| Typ | Common Stock |
| Marktkapitalisierung | 21,27 Mrd. USD |
| Beta | 0,65 |
| Dividendenrendite | 3,26 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2,895,000,000 | 252,000,000 | 2.24 | 16,673,000,000 | 7,366,000,000 |
| 2025-12-31 | 10-K | 11,035,000,000 | 992,000,000 | 8.75 | 16,225,000,000 | 7,170,000,000 |
| 2025-09-30 | 10-Q | 2,816,000,000 | 245,000,000 | 2.16 | 16,197,000,000 | 7,258,000,000 |
| 2025-06-30 | 10-Q | 2,761,000,000 | 282,000,000 | 2.47 | 15,969,000,000 | 7,228,000,000 |
| 2025-03-31 | 10-Q | 2,652,000,000 | 220,000,000 | 1.94 | 15,797,000,000 | 6,929,000,000 |
| 2024-12-31 | 10-K | 9,872,000,000 | 871,000,000 | 7.69 | 16,153,000,000 | 6,778,000,000 |
| 2024-09-30 | 10-Q | 2,488,000,000 | 226,000,000 | 1.99 | 16,095,000,000 | 6,809,000,000 |
| 2024-06-30 | 10-Q | 2,397,000,000 | 229,000,000 | 2.03 | 13,881,000,000 | 6,617,000,000 |
| 2024-03-31 | 10-Q | 2,366,000,000 | 194,000,000 | 1.72 | 13,954,000,000 | 6,432,000,000 |
| 2023-12-31 | 10-K | 9,252,000,000 | 854,000,000 | 7.49 | 14,022,000,000 | 6,307,000,000 |
| 2023-09-30 | 10-Q | 2,295,000,000 | 225,000,000 | 1.96 | 13,482,000,000 | 6,425,000,000 |
| 2023-06-30 | 10-Q | 2,338,000,000 | 235,000,000 | 2.05 | 13,425,000,000 | 6,249,000,000 |
| 2023-03-31 | 10-Q | 2,331,000,000 | 202,000,000 | 1.78 | 12,794,000,000 | 6,050,000,000 |
| 2022-12-31 | 10-K | 9,883,000,000 | 946,000,000 | 7.97 | 12,837,000,000 | 5,893,000,000 |
| 2022-09-30 | 10-Q | 2,486,000,000 | 256,000,000 | 2.17 | 13,223,000,000 | 6,235,000,000 |
| 2022-06-30 | 10-Q | 2,453,000,000 | 234,000,000 | 1.96 | 13,312,000,000 | 6,411,000,000 |
| 2022-03-31 | 10-Q | 2,611,000,000 | 355,000,000 | 2.92 | 13,442,000,000 | 6,377,000,000 |
| 2021-12-31 | 10-K | 10,788,000,000 | 1,995,000,000 | 15.55 | 13,611,000,000 | 6,444,000,000 |
| 2021-09-30 | 10-Q | 2,774,000,000 | 505,000,000 | 4.02 | 13,572,000,000 | 6,392,000,000 |
| 2021-06-30 | 10-Q | 2,550,000,000 | 631,000,000 | 4.96 | 12,861,000,000 | 5,899,000,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 14,392,082 | 0 | 14,392,082 | 2,497,458,052 | Neu | +100,0% | |
| BlackRock, Inc. | 9,459,218 | 0 | 9,459,218 | 1,641,458,028 | Neu | +100,0% | |
| STATE STREET CORP | 5,382,547 | 0 | 5,382,547 | 934,033,381 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 4,145,896 | 0 | 4,145,896 | 719,437,502 | Neu | +100,0% | |
| Boston Partners | 3,913,326 | 0 | 3,913,326 | 680,020,198 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3,028,207 | 0 | 3,028,207 | 523,515,466 | Neu | +100,0% | |
| MORGAN STANLEY | 2,693,568 | 0 | 2,693,568 | 467,415,402 | Neu | +100,0% | |
| VICTORY CAPITAL MANAGEMENT INC | 2,126,422 | 0 | 2,126,422 | 368,998,036 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 1,931,548 | 0 | 1,931,548 | 335,203,671 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 1,769,093 | 0 | 1,769,093 | 306,990,631 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,762,925 | 0 | 1,762,925 | 305,920,455 | Neu | +100,0% | |
| Invesco Ltd. | 1,666,979 | 0 | 1,666,979 | 289,270,867 | Neu | +100,0% | |
| EdgePoint Investment Group Inc. | 1,661,072 | 0 | 1,661,072 | 288,245,824 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 1,622,938 | 0 | 1,622,938 | 281,628,383 | Neu | +100,0% | |
| DAVIS SELECTED ADVISERS | 1,589,883 | 0 | 1,589,883 | 275,895,498 | Neu | +100,0% | |
| NORGES BANK | 1,322,663 | 0 | 1,322,663 | 229,521,710 | Neu | +100,0% | |
| FMR LLC | 1,202,254 | 0 | 1,202,254 | 208,627,187 | Neu | +100,0% | |
| UBS Group AG | 1,114,451 | 0 | 1,114,451 | 193,390,683 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,078,573 | 0 | 1,078,573 | 187,164,772 | Neu | +100,0% | |
| FIDUCIARY MANAGEMENT INC /WI/ | 1,046,921 | 0 | 1,046,921 | 181,672,201 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 870,500 | 0 | 870,500 | 151,058,412 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 846,935 | 0 | 846,935 | 146,968,630 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 813,454 | 0 | 813,454 | 141,158,650 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 751,054 | 0 | 751,054 | 130,330,401 | Neu | +100,0% | |
| Legal & General Group Plc | 742,974 | 0 | 742,974 | 128,928,276 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 733,456 | 0 | 733,456 | 127,276,620 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 632,407 | 0 | 632,407 | 109,741,587 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 609,081 | 0 | 609,081 | 105,693,826 | Neu | +100,0% | |
| Squarepoint Ops LLC | 575,900 | 0 | 575,900 | 99,935,927 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 531,286 | 0 | 531,286 | 92,196,063 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 504,936 | 0 | 504,936 | 87,621,544 | Neu | +100,0% | |
| CRAWFORD INVESTMENT COUNSEL INC | 496,499 | 0 | 496,499 | 86,157,518 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 463,282 | 0 | 463,282 | 80,393,391 | Neu | +100,0% | |
| Artemis Investment Management LLP | 460,725 | 0 | 460,725 | 79,949,609 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 402,034 | 0 | 402,034 | 69,764,960 | Neu | +100,0% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 350,249 | 0 | 350,249 | 60,778,709 | Neu | +100,0% | |
| BARCLAYS PLC | 333,302 | 0 | 333,302 | 57,837,898 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 328,734 | 0 | 328,734 | 57,045,211 | Neu | +100,0% | |
| Advisors Capital Management, LLC | 313,838 | 0 | 313,838 | 54,460,311 | Neu | +100,0% | |
| CITIGROUP INC | 309,817 | 0 | 309,817 | 53,762,459 | Neu | +100,0% | |
| Swiss National Bank | 306,500 | 0 | 306,500 | 53,186,945 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 299,628 | 0 | 299,628 | 51,994,447 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 276,463 | 0 | 276,463 | 47,974,507 | Neu | +100,0% | |
| Quantinno Capital Management LP | 269,597 | 0 | 269,597 | 46,783,330 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 228,731 | 0 | 228,731 | 39,691,000 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 228,057 | 0 | 228,057 | 39,574,731 | Neu | +100,0% | |
| HSBC HOLDINGS PLC | 227,107 | 0 | 227,107 | 39,488,131 | Neu | +100,0% | |
| BANK OF MONTREAL /CAN/ | 217,384 | 0 | 217,384 | 37,722,720 | Neu | +100,0% | |
| BAHL & GAYNOR INC | 187,288 | 0 | 187,288 | 32,500,087 | Neu | +100,0% | |
| SOUTH PLAINS FINANCIAL, INC. | 178 | 0 | 178 | 30,888,000 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-20 | Lassiter Wright III | Director | Small Acquisition | 6 | 194.70 | 1,168.19 | +0,2% | |
| 2026-04-20 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Small Acquisition | 39 | 194.70 | 7,593.26 | +1,2% | |
| 2026-04-20 | CARTER ROBERT B | Director | Small Acquisition | 7 | 194.70 | 1,362.89 | +0,2% | |
| 2026-04-20 | Plewman Patrick | Officer, SVP for Diagnostic Services | Small Acquisition | 49 | 194.70 | 9,540.25 | +1,5% | |
| 2026-04-20 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Small Acquisition | 37 | 194.70 | 7,203.75 | +1,1% | |
| 2026-03-05 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -3,878 | 206.21 | -799,682.38 | -121,9% | |
| 2026-03-05 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -5,558 | 206.21 | -1,146,115.18 | -174,7% | |
| 2026-03-05 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -2,855 | 206.21 | -588,729.55 | -89,7% | |
| 2026-03-04 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -2,628 | 204.86 | -538,372.08 | -82,1% | |
| 2026-03-03 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -526 | 207.73 | -109,265.98 | -16,7% | |
| 2026-03-03 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -410 | 207.73 | -85,169.30 | -13,0% | |
| 2026-03-03 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -632 | 207.73 | -131,285.36 | -20,0% | |
| 2026-03-02 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -10,000 | 212.52 | -2,125,200.00 | -323,9% | |
| 2026-02-19 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -1,433 | 204.83 | -293,521.39 | -44,7% | |
| 2026-02-19 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -958 | 204.83 | -196,227.14 | -29,9% | |
| 2026-02-19 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -1,111 | 204.83 | -227,566.13 | -34,7% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -351 | 209.10 | -73,394.94 | -11,2% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -10,573 | 205.21 | -2,169,655.73 | -330,7% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -10,122 | 206.37 | -2,088,883.21 | -318,4% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -3,500 | 207.08 | -724,787.70 | -110,5% | |
| 2026-02-13 | Doherty Catherine T. | Officer, EVP, Regional Businesses | Open Market Sale | -1,619 | 208.21 | -337,093.12 | -51,4% | |
| 2026-02-10 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -5,662 | 204.00 | -1,155,048.00 | -176,1% | |
| 2026-01-28 | Lassiter Wright III | Director | Small Acquisition | 7 | 183.51 | 1,284.57 | +0,2% | |
| 2026-01-28 | Gregg Vicky B | Director | Small Acquisition | 67 | 183.51 | 12,295.37 | +1,9% | |
| 2026-01-28 | CARTER ROBERT B | Director | Small Acquisition | 6 | 183.51 | 1,101.06 | +0,2% | |
| 2026-01-28 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Small Acquisition | 16 | 183.52 | 2,936.26 | +0,4% | |
| 2026-01-28 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Small Acquisition | 15 | 183.51 | 2,752.65 | +0,4% | |
| 2025-11-25 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -4,747 | 192.97 | -916,036.66 | -139,6% | |
| 2025-11-25 | Gregg Vicky B | Director | Open Market Sale | -1,250 | 191.76 | -239,700.00 | -36,5% | |
| 2025-11-25 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -41,004 | 192.27 | -7,883,900.59 | -1201,7% | |
| 2025-11-25 | Davis J. E. | Director, Officer, CEO and President | Open Market Sale | -9,342 | 191.59 | -1,789,822.57 | -272,8% | |
| 2025-11-18 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Open Market Sale | -7,946 | 187.35 | -1,488,683.10 | -226,9% | |
| 2025-10-22 | PFEIFFER GARY M | Director | Open Market Sale | -1,482 | 182.40 | -270,316.80 | -41,2% | |
| 2025-09-26 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -144 | 188.66 | -27,166.77 | -4,1% | |
| 2025-09-26 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -83 | 187.22 | -15,539.24 | -2,4% | |
| 2025-09-24 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -175 | 187.02 | -32,729.03 | -5,0% | |
| 2025-09-23 | PREVOZNIK MICHAEL E | Officer, SVP & General Counsel | Open Market Sale | -28,288 | 187.12 | -5,293,312.79 | -806,8% | |
| 2025-08-21 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -1,975 | 185.00 | -365,375.00 | -55,7% | |
| 2025-08-19 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -4,532 | 183.00 | -829,356.00 | -126,4% | |
| 2025-08-15 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -1,975 | 180.00 | -355,500.00 | -54,2% | |
| 2025-08-06 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -3,560 | 175.00 | -623,000.00 | -95,0% | |
| 2025-08-06 | Plewman Patrick | Officer, SVP for Diagnostic Services | Open Market Sale | -1,975 | 175.00 | -345,625.00 | -52,7% | |
| 2025-07-31 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -2,210 | 170.00 | -375,700.00 | -57,3% | |
| 2025-07-30 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -3,045 | 167.40 | -509,733.00 | -77,7% | |
| 2025-07-30 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Open Market Sale | -5,224 | 167.40 | -874,497.60 | -133,3% | |
| 2025-07-21 | Gregg Vicky B | Director | Small Acquisition | 79 | 167.50 | 13,232.11 | +2,0% | |
| 2025-07-21 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Small Acquisition | 17 | 167.49 | 2,847.35 | +0,4% | |
| 2025-07-21 | KUPPUSAMY KARTHIK | Officer, SVP, Clinical Solutions | Small Acquisition | 27 | 167.50 | 4,522.45 | +0,7% | |
| 2025-07-21 | CARTER ROBERT B | Director | Small Acquisition | 7 | 167.51 | 1,172.54 | +0,2% | |
| 2025-07-21 | Plewman Patrick | Officer, SVP for Diagnostic Services | Small Acquisition | 80 | 167.49 | 13,399.52 | +2,0% | |
| 2025-07-21 | SAMAD SAM | Officer, Executive Vice President & CFO | Small Acquisition | 72 | 167.50 | 12,059.71 | +1,8% | |
| 2025-07-21 | Lassiter Wright III | Director | Small Acquisition | 7 | 167.51 | 1,172.54 | +0,2% | |
| 2025-05-13 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Open Market Sale | -874 | 175.31 | -153,220.94 | -23,4% | |
| 2025-05-12 | DELANEY MARK E | Officer, SVP & Chief Commercial Officer | Open Market Sale | -874 | 175.72 | -153,579.28 | -23,4% |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| OPPENHEIMER & CO INC | 38,731 | 7,590,501 | 95.61 |
| WASHINGTON CAPITAL MANAGEMENT, INC | 1,780 | 348,844 | 4.39 |